FibroGen, Inc. has announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. Under the t...
Hong Kong Baptist University (HKBU) has established a strategic partnership with Hong Kong Baptist Hospital (HKBH) in it...
A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Facult...
Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...
Indian pharmaceutical firm Zydus Lifesciences has announced that its wholly owned subsidiary, Zydus Lifesciences...
Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its globa...
Infinitus (China) Company has secured approval for its Sino-British Joint Laboratory on Health and Ageing project. This ...
Bowtie, Hong Kong’s first virtual insurer, has collaborated with Gleneagles Hospital Hong Kong and Pfizer Hong Kon...
The Hong Kong Polytechnic University (PolyU) and Shandong First Medical University (SDFMU) have signed a Memorandum of U...
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...
Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...
The Hong Kong Polytechnic University (PolyU) and Peking University Third Hospital (PUTH) have signed a Memorandum of Und...
PanopticAI, a leading innovator in remote patient monitoring, has received 510(k) clearance from the US Food and Drug Ad...
China-based Yuwell Medical recently held its 2025 Global Core Partner Conference in Dubai, and announced ...
China's State Administration for Market Regulation (SAMR) recently unveiled the Compliance G...
Biophytis SA, a Paris-based clinical-stage biotechnology company specialising in the development of treatments for age-r...
Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have succe...
The Brunei Ministry of Health (MoH), in partnership with Borneo Genomics Innovation (BGIB), a joint venture of China's B...
